Breaking News

Marken Expands Clinical Trial Services

Critical need for patients to receive treatment at home spurs sponsor requests

By: Contract Pharma

Contract Pharma Staff

The prevalence of shelter-in-place restrictions and reduced hospital capacity due to the coronavirus pandemic has resulted in the first global disruption to traditional onsite clinical trials. According to Marken, Direct to/from Patient (DTP/DFP) and Home Healthcare (HHC) services provide solutions to keep clinical trials going, while maintaining patient safety, by shipping treatments directly to participant’s homes. Through DFP services, biological samples can be retrieved from a patient&...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters